Authors:
RIESKE K
DOMULA M
LIEBERT UG
GRULICH S
HANDRICK W
BIERBACH U
LENK H
Citation: K. Rieske et al., CLINICAL SYMPTOMS AND EPIDEMIOLOGY OF HEPATITIS-C VIRUS-INFECTIONS INIMMUNOCOMPROMISED CHILDREN WITH MALIGNANT DISEASES, Klinische Padiatrie, 210(4), 1998, pp. 274-278
Authors:
LAUB R
DIGIAMBATTISTA M
FONDU P
BRACKMANN HH
LENK H
SCANDELLA D
Citation: R. Laub et al., RESTRICTED EPITOPE SPECIFICITY OF FACTOR-VIII INHIBITORS WHICH APPEARED IN PREVIOUSLY TREATED HEMOPHILIACS AFTER INFUSION WITH OCTAVI SD PLUS, Thrombosis and haemostasis, 1997, pp. 2409-2409
Citation: R. Durr et H. Lenk, FUNCTIONALITY AND FLEXIBILITY OF SIGNS - THE SCHEMATIZATION OF MOVEMENTS IN SPORTS, Zeitschrift fur Semiotik, 19(4), 1997, pp. 435-451
Authors:
KLINGE J
AUERSWALD G
BUDDE U
KLOSE H
KREUZ W
LENK H
SCANDELLA D
Citation: J. Klinge et al., THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY, Blood, 90(10), 1997, pp. 2056-2056
Authors:
DOPNER S
HILDEBRANDT P
MAUK AG
LENK H
STEMPFLE W
Citation: S. Dopner et al., ANALYSIS OF VIBRATIONAL-SPECTRA OF MULTICOMPONENT SYSTEMS - APPLICATION TO PH-DEPENDENT RESONANCE RAMAN-SPECTRA OF FERRICYTOCHROME-C, SPECT ACT A, 52(5), 1996, pp. 573-584
Authors:
GILLES JG
DESQUEPER B
LENK H
VERMYLEN J
SAINTREMY JM
Citation: Jg. Gilles et al., NEUTRALIZING ANTIIDIOTYPIC ANTIBODIES TO FACTOR-VIII INHIBITORS AFTERDESENSITIZATION IN PATIENTS WITH HEMOPHILIA-A, The Journal of clinical investigation, 97(6), 1996, pp. 1382-1388
Authors:
KLOSE HJ
AUERSWALD G
ESCURIOLAETTINGSHAUSEN C
KREUZ W
LENK H
MARTINEZSAGUER I
BUDDE U
Citation: Hj. Klose et al., INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH), Blood, 88(10), 1996, pp. 3031-3031
Citation: J. Guy et al., SUCCESSFUL FACTOR-VIII DESENSITIZATION IS ACCOMPANIED BY AN INCREASE IN ANTI-FVIII ANTIIDIOTYPIC ANTIBODIES WITHOUT REDUCTION OF ANTI-FVIIIANTIBODY-TITERS, Thrombosis and haemostasis, 73(6), 1995, pp. 1011-1011
Citation: H. Lenk et al., VON-WILLEBRAND DISEASE TYPE-III WITH INHIBITOR AND APPLICATION OF IMMUNE TOLERANCE TREATMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1168-1168
Citation: E. Ziegler et H. Lenk, CORRUPTION AT THE DATA CAPTURE STAGE AND GOOD LABORATORY PRACTICES, Journal of AOAC International, 77(3), 1994, pp. 789-793